While a variety of adult cancers become less reliant on the initiating set of mutations as they progress and acquire new mutations, our observation that the EWSR1-WT1 signature is enhanced in recurrent/metastatic DSRCTs suggests recurrent tumors may actually be more reliant on the EWSR1-WT1 fusion oncogene [58, 59]. The gene discussed is WT1; the disease is cancer.